今海医疗科技(02225)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02225 今海医疗科技

未开盘 09-02 16:08:07

4.435

-0.100

-2.21%

最高4.800	最低4.340	成交量349.00万
今开4.600	昨收4.535	日振幅10.14%
总市值235.01亿	流通市值235.01亿	总股本52.99亿
成交额1,592万	换手率0.07%	流通股本52.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02225","market":"HK","secType":"STK","nameCN":"今海医疗科技","latestPrice":4.435,"timestamp":1788336487003,"preClose":4.535,"halted":0,"volume":3490000,"delay":0,"changeRate":-0.022050716648291186,"floatShares":5299000000,"shares":5299000000,"eps":-0.0201980492938418,"marketStatus":"未开盘","change":-0.1,"latestTime":"09-02 16:08:07","open":4.6,"high":4.8,"low":4.34,"amount":15919250,"amplitude":0.101433,"askPrice":4.44,"askSize":20000,"bidPrice":4.395,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-0.013078761302060054,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":0,"adr":0,"listingDate":1508169600000,"exchange":"SEHK","adjPreClose":4.535,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"volumeRatio":0.516593,"lotSize":5000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02225","defaultTab":"news","newsList":[{"id":"2664899822","title":"港股异动 | 今海医疗科技(02225)涨超5% 上半年收益同比大幅增超1.3倍 战略重心转向高附加值医疗器械赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2664899822","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664899822?lang=zh_cn&edition=full","pubTime":"2026-09-02 14:04","pubTimestamp":1788329049,"startTime":"0","endTime":"0","summary":"消息面上，近期，今海医疗科技披露2026年中期业绩。2026年上半年，集团实现收益3402.1万新加坡元，同比大幅增长134.16%，展现出强劲的销售增长动能。业务端，2026年上半年，公司收入结构显著优化，战略重心已成功从传统劳务服务转向高附加值的医疗器械赛道。继2025年医疗器械销售收益实现良好增长后，2026年上半年该业务收益同比激增301.5%，达到2542.7万新加坡元，可持续增长动力充足。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","RSPH","GDOC","BK1583","KCAI","MEDX","02225","HART","LGHT","09996","BK1100","IEIH","BK4585","VXUS","PTH","BK1150","AGNG","159883","MDEV","LNGR","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138957716","title":"今海医疗科技更新2026年8月股份变动月报表，股本保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1138957716","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138957716?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:12","pubTimestamp":1788250364,"startTime":"0","endTime":"0","summary":"今海医疗科技股份有限公司于2026年9月1日公告了2026年8月的股份变动月报表。公告显示，公司本月期间内未发生新增股份发行、购回或注销等情况，各类股本结构维持稳定。根据公告，截至2026年8月31日，公司法定/注册股本数量为8,000,000,000股，面值每股0.0025港元，对应注册股本总额20,000,000港元，较上月底无变化。已发行普通股为5,299,000,000股，无库藏股，亦无变动。本月并无因行使期权而发行新股或转让库藏股的记录。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663117020","title":"今海医疗科技2026年上半年收益同比增长134.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663117020","media":"中国财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663117020?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:03","pubTimestamp":1788159809,"startTime":"0","endTime":"0","summary":"今海医疗科技股份有限公司（股份代号：2225）公布截至2026年6月30日的六个月未经审核中期业绩。报告期内，该公司收益为3402.1万新加坡元（注：1新加坡元≈5.2605人民币，2026年6月30日），较去年同期1452.9万新加坡元增长134.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860055916.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860055916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02225","BK1150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663601783","title":"盈利修复态势明确，今海医疗科技(02225)长期价值释放可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2663601783","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663601783?lang=zh_cn&edition=full","pubTime":"2026-08-29 19:20","pubTimestamp":1788002458,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近期，今海医疗科技披露2026年中期业绩，交出一份颇具看点的阶段性答卷。从行业视角来看，中国医疗体系升级、居民健康消费水平提升及肿瘤早筛观念普及，持续推升微创诊疗的刚性需求，传统开放手术正加速向微创术式切换。展望2026年下半年及更长远周期，今海医疗若能持续把握中国及亚太地区微创外科渗透率提升的产业机遇，同时有效应对行业竞争与政策变数，有望在国产高端设备进口替代进程中占据更为有利的竞争位置。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1150","02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194257935","title":"今海医疗科技2026年上半年营收3,402.10万新加坡元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194257935","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194257935?lang=zh_cn&edition=full","pubTime":"2026-08-27 16:54","pubTimestamp":1787820859,"startTime":"0","endTime":"0","summary":"今海医疗科技发布的财报显示，2026年上半年实现营收3,402.10万新加坡元，与2025年同期的1,452.90万新加坡元相比增长约134.2%。同期销售及服务成本从1,244.70万新加坡元增至2,739.90万新加坡元，主要用于支持销量增长。毛利从208.20万新加坡元提升至662.20万新加坡元，毛利率相应由14.3%增至19.5%。微创手术解决方案及医疗产品和相关服务板块上半年营收为2,542.70万新加坡元，同比增长301.5%，主要得益于中国市场需求的增长。其他业务营收31.30万新加坡元，同比下降14.7%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"今海医疗科技2026年上半年营收3,402.10万新加坡元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662743774","title":"今海医疗科技(02225)发布中期业绩 收益3402.1万新加坡元 同比大幅增加134.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662743774","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662743774?lang=zh_cn&edition=full","pubTime":"2026-08-27 16:52","pubTimestamp":1787820773,"startTime":"0","endTime":"0","summary":"智通财经APP讯，今海医疗科技(02225)发布截至2026年6月30日止6个月中期业绩，集团收益3402.1万新加坡元，同比增加134.16%;股东应占亏损436.2万新加坡元，同比收窄57.46%;每股亏损0.08新加坡分。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486941.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1150","02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661428042","title":"港股异动 | 今海医疗科技早盘涨超11%，获纳入恒生综合指数，后续有望进入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2661428042","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661428042?lang=zh_cn&edition=full","pubTime":"2026-08-24 10:16","pubTimestamp":1787537797,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，今海医疗科技(02225)早盘涨超11%，截至发稿，涨10.86%，报5.36港元，成交额1121.77万港元。消息面上，恒生指数公司发布季度检讨结果，恒生综合指数变动将于9月4日(星期五)收市后实施并于9月7日(星期一)起生效。其中，今海医疗科技获纳入恒生综合指数，后续有可能被调入港股通，因其满足了包括市值、流动性等在内的一系列标准。8月3日，今海医疗科技发布公告，宣布委任马成栋先生为集团首席营销官，自2026年8月3日起生效，初步任期一年。根据公告，马成栋将主要负责集团产品的营销策略、市场准入、学术推广及销售与渠道营运，并监督集团医疗器械及设备产品的商业化工作。","market":"sh","thumbnail":"https://static.tigerbbs.com/2a3253accc7322a3db322a8557ee9834","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/2a3253accc7322a3db322a8557ee9834"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483981.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1150","FLHK","BK4585","BK4588","02225","KCAI","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262244","title":"今海医疗科技(02225.HK)获纳入恒生综合指数 有望成为港股通标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262244","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661262244?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:59","pubTimestamp":1787309944,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02225","HSCI","BK1150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262226","title":"今海医疗科技(02225)获纳入恒生综合指数 有望成为港股通标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262226","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661262226?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:59","pubTimestamp":1787309944,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月21日，恒生指数公司公布截至2026年6月30日之恒生指数系列季度检讨结果，其中今海医疗科技(02225)获纳入恒生综合指数。恒生综合指数变动将于9月4日(星期五)收市后实施并于9月7日(星期一)起生效，届时沪深交易所会相应调整港股通可投资标的范围。今海医疗科技有可能被调入港股通，因其满足了包括市值、流动性等在内的一系列标准。8月3日，今海医疗科技发布公告，宣布委任马成栋先生为集团首席营销官，自2026年8月3日起生效，初步任期一年。根据公告，马成栋将主要负责集团产品的营销策略、市场准入、学术推广及销售与渠道营运，并监督集团医疗器械及设备产品的商业化工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483467.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02225","BK1150","HSCI","FLHK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190512912","title":"财报前瞻｜今海医疗科技毛利率承压，商业化推进与估值分歧成主线","url":"https://stock-news.laohu8.com/highlight/detail?id=1190512912","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190512912?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:22","pubTimestamp":1787188973,"startTime":"0","endTime":"0","summary":"今海医疗科技将于2026年8月27日盘后披露中期业绩，市场关注商业化推进节奏与费用投入节律对利润结构的影响。目前未形成可核实的一致预测，公司上季财报亦未披露本季度的收入、毛利率、净利润或净利率、调整后每股收益等量化指引，市场对本季表现聚焦于商业化推进与费用开支变动对利润端的综合影响。财务端最突出的变化在于毛利率与净利率的双向承压，结合费用与产能投放节奏，利润短期仍处改善蓄力阶段。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜今海医疗科技毛利率承压，商业化推进与估值分歧成主线","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151056070","title":"一周港股牛熊榜 | 真健康医疗-B受手术机器人收费框架催化涨逾32%，中国星集团获资金追捧涨逾30%；东阳光药利好兑现跌近15%，京能清洁能源盈警拖累","url":"https://stock-news.laohu8.com/highlight/detail?id=1151056070","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151056070?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:18","pubTimestamp":1786094280,"startTime":"0","endTime":"0","summary":"本周涨幅居前个股中，真健康医疗-B受手术机器人收费框架落地及行业商业化预期推动，累计上涨32.61%；中国星集团在影视娱乐股活跃及大手成交带动下上涨30.69%；海清智元获东吴证券国际首次覆盖并给予“买入”评级，累计上涨30.68%。按2025年经皮穿刺手术机器人收入计，公司在中国位居首位，市场份额为28.0%。","market":"hk","thumbnail":"https://static.tigerbbs.com/144fcf63ccaceb7d59c371695c704fb3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/144fcf63ccaceb7d59c371695c704fb3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01392","02706","02225","02697","00326"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1167350117","title":"今海医疗科技(02225)拟于2026年8月27日召开董事会审议中期业绩及股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1167350117","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167350117?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:36","pubTimestamp":1785832564,"startTime":"0","endTime":"0","summary":"今海医疗科技股份有限公司(02225)8月4日发布公告称，公司董事会已定于2026年8月27日(星期四)召开会议。届时，董事会将审议并批准包括截至2026年6月30日止六个月的中期业绩及可能派发的中期股息等事项。\n公告显示，目前公司董事会共由八名董事组成，其中包括四名执行董事、 一名非执行董事及三名独立非执行董事。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656320483","title":"今海医疗科技(02225)：马成栋获委任为首席营销官","url":"https://stock-news.laohu8.com/highlight/detail?id=2656320483","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656320483?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:13","pubTimestamp":1785751992,"startTime":"0","endTime":"0","summary":"智通财经APP讯，今海医疗科技(02225)发布公告，马成栋先生获委任为集团首席营销官，自2026年8月3日起生效，初步任期为一年，主要负责集团产品的营销策略、市场准入、学术推广及销售与渠道营运，并监督集团医疗器械及设备产品的商业化工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475331.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02225","BK1150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125920054","title":"今海医疗科技更新2026年7月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1125920054","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125920054?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:18","pubTimestamp":1785748737,"startTime":"0","endTime":"0","summary":"今海医疗科技股份有限公司于2026年8月3日披露2026年7月的股份变动月报表。报告显示，截至2026年7月31日，公司法定股本总额保持在8,000,000,000股普通股，面值每股HKD0.0025，合计HKD20,000,000，与上月同步数据相同。根据公告，今海医疗科技自2023年12月29日起实施的股份期权计划共有445,960,000份期权，截至7月底数量未发生变化，当月亦无新股因行使期权而发行或从库存转让。公司表示，所有申报及变动事项均已遵守香港联交所《上市规则》和相关法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656326429","title":"港股异动 | 今海医疗科技(02225)涨超6% 微创手术器械市场发展迅速 公司切入内窥镜国产替代黄金赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2656326429","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656326429?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:16","pubTimestamp":1785741407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，今海医疗科技涨超6%，截至发稿，涨5.63%，报3.845港元，成交额1041.77万港元。消息面上，据MordorIntelligence报告指出，随着行业参与者适应不断变化的临床标准及患者需求，微创手术器械市场发展迅速。中国微创手术器械市场为全球增长最快的手术器械市场之一。报告还指出，中国微创手术器械行业2025年市场规模为17.1亿美元，预计2030年将增至26.8亿美元，复合年增长率为9.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GLDM","SHNY","JNUG","KCAI","DBC","DZZ","MGCmain","QOmain","GDXD","IAUM","VXUS","GDXJ","IAU","CEF","DUST","159831","AAAU","GLTR","JDST","GCmain","BEGS","OUNZ","KSTR","BAR","1OZmain","BTGD","XHE","GLL","GOLY","SGOL","DULL","GBUG","GDX","GDXU","USG","PALL","SGDM","RING","FAAR","DGP","GDXY","UYM","PHYS","UGL","GOAU","02225","PICK","FGDL","IAUI","XME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653822207","title":"港股异动 | 今海医疗科技(02225)涨超14% 获韩国投资者逆势加仓 公司深耕国内微创手术领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2653822207","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653822207?lang=zh_cn&edition=full","pubTime":"2026-07-21 15:52","pubTimestamp":1784620338,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，今海医疗科技涨超14%，截至发稿，涨14.64%，报4.15港元，成交额1.47亿港元。港股市场方面，包括今海医疗科技在内的标的获净买入金额也在百万美元以上。据悉，今海医疗专注于高端医疗内窥镜等微创医疗器械整体解决方案，凭借近年来在内窥镜技术研发领域持续深耕，今海取得了多项重要突破。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","KCAI","02225","BK1150","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155480992","title":"今海医疗科技6月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1155480992","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155480992?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:06","pubTimestamp":1782979589,"startTime":"0","endTime":"0","summary":"今海医疗科技于2026年7月2日发布截至2026年6月30日的证券变动月报表。公告显示，公司截至本月底的法定/注册股本及已发行股份数均保持不变，股本规模继续维持稳定。此外，根据公司于2023年12月29日采纳的股份期权计划，期末股份期权数量为445,960,000份，与上月相比无变动，报告期内并未产生新的股份发行或需从库存转让股份的情形。公司在公告中确认已遵守香港联交所《上市规则》及相关法律规定。该公告由公司秘书黄文耀签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641085091","title":"降价、分化、出海与咖啡，新茶饮六小龙开始算 “生态账”","url":"https://stock-news.laohu8.com/highlight/detail?id=2641085091","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641085091?lang=zh_cn&edition=full","pubTime":"2026-06-08 11:28","pubTimestamp":1780889289,"startTime":"0","endTime":"0","summary":"蜜雪稳坐王座，体量碾压，增长态势强劲。但其利润表现亮眼，净利润8.21亿元，同比大增71.2%。门店总数从1798家缩减至1646家，首次出现门店负增长。增速分化的原因，与门店经营状态密切相关。霸王茶姬大中华区单店日均GMV从2023年Q4高峰期的1.91万元，连续8个季度下滑至2025年Q4的1.12万元。截至6月2日，蜜雪集团以1081.91亿港元的总市值稳居头把交椅。“六小龙”给出了不同的答案。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1780578798494969439","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1110","BK1233","02226","BK4526","BK4610","LU0348766576.USD","BK4539","CHA","02150","BK4209","BK1616","BK1150","LU0348767384.USD","BK1587","BK1237","02555","02198","02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143551022","title":"今海医疗科技更新5月股份变动月报表，已发行股份增至52.99亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1143551022","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143551022?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:06","pubTimestamp":1780301165,"startTime":"0","endTime":"0","summary":"今海医疗科技股份有限公司于2026年6月1日发布截至2026年5月31日的月报表。公告显示，公司法定/注册股本维持与上月相同，数额为2,000万港元，股份面值为每股0.0025港元，法定/注册股份总数保持在80亿股。在已发行股份方面，5月期内公司普通股数量由上月底的52.90亿股增加至52.99亿股，增发9,000,000股。库藏股数量持续为0，已发行股份套数相应增长至52.99亿股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638066685","title":"异动股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638066685","media":"财华网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638066685?lang=zh_cn&edition=full","pubTime":"2026-05-28 16:20","pubTimestamp":1779956406,"startTime":"0","endTime":"0","summary":"05月28日收盘，截至发稿，港股跌幅榜前十名分别为智中国际跌幅29.76%、金石资本集团跌幅25.38%、高奥士人才集团跌幅24.05%、华亿金控(新)跌幅21.88%、亦辰集团跌幅20.67%、GUANZE MEDICAL跌幅20.00%、华联国际跌幅19.13%、迪米生活控股跌幅18.92%、今海医疗科技跌幅18.04%、迪诺斯环保跌幅17.32%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/28162057239515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1197","BK1212","08042","00969","02427","BK1156","01452","BK1183","08365","BK1239","BK1148","01160","02225","BK1147","06063","01667","BK1150","08123"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://kttgroup.com.sg/","stockEarnings":[{"period":"1week","weight":-0.208},{"period":"1month","weight":0.1228},{"period":"3month","weight":0.2117},{"period":"6month","weight":1.2979},{"period":"1year","weight":6.6466},{"period":"ytd","weight":2.548}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0023},{"period":"6month","weight":-0.0173},{"period":"1year","weight":-0.0073},{"period":"ytd","weight":-0.0125}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"今海医疗科技股份有限公司是一家总部位于新加坡的投资控股公司。该公司及其运营子公司为建筑行业提供人力外包及配套服务、宿舍服务、信息技术（IT）服务、建筑配套服务，以及微创手术解决方案、医疗产品及相关服务。该公司的业务范围覆盖新加坡和中华人民共和国。今海医疗是一家提供人力资源和空间管理的综合解决方案提供商。香港今海企业发展有限公司是该公司的子公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.079873},{"month":2,"riseRate":0.444444,"avgChangeRate":0.213927},{"month":3,"riseRate":0.777778,"avgChangeRate":0.120644},{"month":4,"riseRate":0.333333,"avgChangeRate":0.069575},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.067852},{"month":6,"riseRate":0.666667,"avgChangeRate":0.015787},{"month":7,"riseRate":0.666667,"avgChangeRate":0.089839},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.001982},{"month":9,"riseRate":0.555556,"avgChangeRate":0.099571},{"month":10,"riseRate":0.375,"avgChangeRate":-0.001574},{"month":11,"riseRate":0.555556,"avgChangeRate":0.116404},{"month":12,"riseRate":0.666667,"avgChangeRate":0.003541}],"exchange":"SEHK","name":"今海医疗科技","nameEN":"JINHAI MED TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"今海医疗科技(02225)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供今海医疗科技(02225)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"今海医疗科技,02225,今海医疗科技股票,今海医疗科技股票老虎,今海医疗科技股票老虎国际,今海医疗科技行情,今海医疗科技股票行情,今海医疗科技股价,今海医疗科技股市,今海医疗科技股票价格,今海医疗科技股票交易,今海医疗科技股票购买,今海医疗科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"今海医疗科技(02225)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供今海医疗科技(02225)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}